0
Skip to Content
Real World Genetics
Our services
Data
Our team
Our customers
Contact Us
Real World Genetics
Our services
Data
Our team
Our customers
Contact Us
Our services
Data
Our team
Our customers
Contact Us

Our customers

Maze Therapeutics

In collaboration with Maze Therapeutics, we are investigating the efficacy of SGLT2i and GLP1-RA medications in patients with and without chronic kidney disease by analyzing real-world data from Finnish healthcare registries. Privacy notice.

Location

Karjalankatu 10

00520, Helsinki

Data security and utilization practices

Our team members are carefully selected based on their expertise in the field. This encompasses not only their data analysis competencies but also their understanding of data handling and management related to sensitive data sets. These data sets include health-related information from medical records or biobanks and can only be acquired based on a strict data permit. Access is strictly monitored and is possible only for contracted and vetted team members from Real World Genetics Oy who are individually named in the application. Any changes must be approved and authorized by the data authority, as Real World Genetics Oy must comply with all rules and regulations concerning the purposes for use, access, and the defined scope under which the data permit has been obtained. Moreover, the data must be processed in a secure environment, which is a top priority for Real World Genetics Oy. In addition to using only the secure computing environment provided by the data authority, Real World Genetics Oy has implemented additional applicable technical and organizational security measures to prevent unauthorized access, modification, or loss of personal data.